000 | 01963 a2200517 4500 | ||
---|---|---|---|
005 | 20250516115611.0 | ||
264 | 0 | _c20130220 | |
008 | 201302s 0 0 eng d | ||
022 | _a1522-1539 | ||
024 | 7 |
_a10.1152/ajpheart.00820.2011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGui, Le | |
245 | 0 | 0 |
_aVentricular tachyarrhythmias in rats with acute myocardial infarction involves activation of small-conductance Ca2+-activated K+ channels. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Heart and circulatory physiology _cJan 2013 |
||
300 |
_aH118-30 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAction Potentials |
650 | 0 | 4 |
_aAlkanes _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xpharmacology |
650 | 0 | 4 |
_aApamin _xpharmacology |
650 | 0 | 4 | _aCardiac Pacing, Artificial |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aElectrocardiography |
650 | 0 | 4 | _aHeart Rate |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
650 | 0 | 4 |
_aQuinolinium Compounds _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aRefractory Period, Electrophysiological |
650 | 0 | 4 |
_aSmall-Conductance Calcium-Activated Potassium Channels _xdrug effects |
650 | 0 | 4 |
_aTachycardia, Ventricular _xetiology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aVentricular Fibrillation _xetiology |
700 | 1 | _aBao, Zhiwei | |
700 | 1 | _aJia, Yinyu | |
700 | 1 | _aQin, Xiaotong | |
700 | 1 | _aCheng, Zixi Jack | |
700 | 1 | _aZhu, Jianhua | |
700 | 1 | _aChen, Qing-Hui | |
773 | 0 |
_tAmerican journal of physiology. Heart and circulatory physiology _gvol. 304 _gno. 1 _gp. H118-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpheart.00820.2011 _zAvailable from publisher's website |
999 |
_c22202213 _d22202213 |